论文部分内容阅读
目的:通过对咳喘停汤加氧雾化吸入治疗慢性阻塞性肺疾病急性加重期(AECOPD)(喘证:痰浊阻肺型)的临床观察,探讨中药治疗慢性阻塞性肺疾病急性加重期(喘证:痰浊阻肺型)的新方药新途径。方法:将收治入院的100例慢性阻塞性肺疾病急性加重期(喘证:痰浊阻肺型)患者随机分为两组。对照组给予常规对症处理,治疗组在常规对症处理的基础上加用咳喘停汤加氧雾化吸入治疗,并对两组患者治疗前后各项指标进行对比。结果:治疗组总有效率96%明显高于对照组76%(P<0.05)。结论:咳喘停汤加氧雾化吸入治疗慢性阻塞性肺疾病急性加重期(AECOPD)(喘证:痰浊阻肺型)疗效显著。
OBJECTIVE: To observe the clinical observation of treating acute exacerbation of chronic obstructive pulmonary disease (AECOPD) (asthma syndrome: phlegm blocking pneumonia type) by using Cough Asthmatic Decoction combined with aerosol inhalation to investigate the effect of traditional Chinese medicine in the treatment of acute exacerbation of chronic obstructive pulmonary disease Asthma card: phlegm blocking lung type) new prescription new way. Methods: One hundred patients admitted to hospital with acute exacerbation of chronic obstructive pulmonary disease (asthma card: phlegm obstruction type) were randomly divided into two groups. The patients in the control group were given conventional symptomatic treatment. The treatment group was treated with the combination of Cough and Stagnation Decoction plus oxygen inhalation therapy on the basis of routine symptomatic treatment, and the indexes of the two groups were compared before and after treatment. Results: The total effective rate 96% in the treatment group was significantly higher than that in the control group 76% (P <0.05). Conclusion: Acute asthma exacerbation of chronic obstructive pulmonary disease (AECOPD) (asthma syndrome: phlegm blocking pneumonia type) has a significant curative effect.